Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1193 of 6351
-
Lab-Grown tumor organoids could guide bladder cancer treatment
Disease control OngoingFrom patients with intermediate risk non-muscle invasive bladder cancer tumor (NMIBC) specimens will be harvested during transurethral resection. Fresh specimens will be cultured as patient derived organoids (PDO). After approx. 10 days, PDO are exposed to different drugs that ar…
Phase 2 • Sponsor: Roland Seiler-Blarer • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Probiotic drops may shield preemies from fatal gut infection
Disease control CompletedProject Summary: The prevalence of preterm birth ranges from 5% to 18% across 184 countries, and an estimated 15 million infants are born preterm globally. These infants with an immature immune system and gastrointestinal tract are at risk of complications of premature birth, wh…
Sponsor: University of Health Sciences Lahore • Aim: Disease control
Last updated Jun 26, 2026 16:23 UTC
-
Could cell-derived vesicles restart the ovaries? a new trial investigates
Disease control CompletedPremature ovarian failure (POF) is a clinical syndrome defined by loss of ovarian activity before the age of 40 years. POF is characterized by menstrual disturbance (amenorrhea or oligomenorrhea) with raised gonadotrophins and low estradiol. The prevalence of POF is 1-2%. Extrace…
Phase 1/2 • Sponsor: Royan Institute • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New test could sharpen diagnosis of narcolepsy and related sleep disorders
Diagnosis CompletedIn humans, selective loss of orexin neurons is responsible for type 1 narcolepsy (NT1), or narcolepsy with cataplexy, or orexin deficiency syndrome. The International Classification of Sleep Disorders 3rd edition (ICSD-3) distinguishes between hypersomnolence of central origin: …
Sponsor: University Hospital, Montpellier • Aim: Diagnosis
Last updated Jul 11, 2026 00:00 UTC
-
Blood pressure drug may extend pregnancy in preeclampsia
Disease control Recruiting nowThe Achieve Trial is a randomized clinical trial to test whether lowering blood pressure to less than 140/90 mmHg in women with hypertensive disorders of pregnancy will prolong pregnancy.
Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New $5 HPV test could save lives in poor countries
Diagnosis OngoingThe purpose of this study is to validate a new low-cost, self-collected HPV screening test (ScreenFire) and compare it to the standard provider collected careHPV, for the detection of high grade cervical cancer.
Sponsor: The Cleveland Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC
-
Which airway device saves more lives? large hospital trial aims to find out
Disease control Recruiting nowThe Hospital Airway Resuscitation Trial (HART) is a cluster-randomized, pragmatic trial of advanced airway management with a strategy of first choice supraglottic airway vs. first choice endotracheal intubation during in-hospital cardiac arrest.
Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a diabetes drug protect kidneys in obesity? new trial investigates
Disease control OngoingWe are doing this study to learn more about how tirzepatide may help fight chronic kidney disease in people with obesity with or without type 2 diabetes (T2D). The study will last about 56 weeks and include up to 12 visits.
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug cocktail shows promise against tough pancreatic cancer
Disease control CompletedThe Phase Ib/II study is an open-label, single-arm, multicenter trial designed to assess the efficacy and safety of Y101D in combination with Gemcitabine and Albumin Paclitaxel as first-line systemic treatment for advanced pancreatic cancer patients. The Phase Ib portion of the s…
Phase 1/2 • Sponsor: Wuhan YZY Biopharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Fat cell therapy shows promise for knee arthritis
Disease control CompletedThis prospective, randomized controlled clinical trial aims to evaluate the clinical and radiological effects of combining stromal vascular fraction (SVF) therapy with arthroscopic microfracture in patients with knee osteoarthritis. A total of 50 patients with symptomatic gonarth…
Sponsor: Istanbul University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could an allergy drug protect kidneys in type 1 diabetes?
Disease control Recruiting nowKidney disease is a common problem among people with type 1 diabetes and can lead to disability, dialysis, and early death. Inflammation plays a key role in the development of kidney disease in type 1 diabetes and targeting leukotrienes, inflammatory chemicals the body releases i…
Phase 4 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for kids with psoriasis: oral drug apremilast under study
Disease control OngoingThe primary objective of this study is to evaluate the efficacy of apremilast in children and adolescents (ages 6 through 17 years) with moderate to severe plaque psoriasis.
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Fasting your way to better blood sugar? new study tests two diet plans
Disease control CompletedTo test whether a lifestyle program featuring one of two forms of intermittent fasting (IER or TRE) can feasibly and effectively improve glycemia in patients with type 2 diabetes, and potentially induce diabetes remission.
Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Could a mood stabilizer help fight colorectal cancer?
Disease control OngoingThe aim of this study is to determine the efficacy of combining the histone deacetylase (HDAC) inhibitor sodium valproate (VPA) with anti-EGFR monoclonal antibody (panitumumab or cetuximab) maintenance in the first-line treatment of patients with RAS wild type metastatic CRC.
Phase 2 • Sponsor: Australasian Gastro-Intestinal Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Precision radiation boost aims to tame High-Risk prostate cancer
Disease control OngoingThis trial is a prospective clinical trial designed to demonstrate the safety and feasibility of whole-pelvis adaptive prostate stereotactic body radiation therapy (SBRT) with a tumor boost to the magnetic resonance (MR)-detected sites of disease. The hypothesis is that this trea…
Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Brain-like software upgrade helps insulin pumps outsmart diabetes
Disease control CompletedThis study is intended to test a Web-based Information Tool (WIT) software providing additional information regarding time in range, GMI, hypo- and hyperglycemia risks, variability tracker, daily glycemic profiles, and potential changes of insulin pump parameters, to users of a c…
Sponsor: Sue Brown • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Magnetic pulses to the brain may restore vision in adult lazy eye
Disease control OngoingAmblyopia, with a prevalence rates of 3% in adult population, is a common cause of vision impairment. It is characterized by impaired vision in one or both eyes because of disruption of normal visual stimuli and underdevelopment of the visual cortex, leads to lifelong visual defi…
Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Long-acting HIV shot studied in patients with severe kidney problems
Disease control CompletedThe purpose of this study is to evaluate the efficacy and safety of CABENUVA (Long-acting Cabotegravir Plus Long-acting Rilpivirine) in patients with HIV infection and severe renal impairment. This study is considered research and is voluntary.
Phase 3 • Sponsor: Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
AI coach: machine learning aims to slash sports injuries and boost sprint times
Disease control CompletedPlaintext The purpose of this study is to evaluate whether a personalized training protocol driven by machine learning can successfully reduce time-loss sports injuries and enhance athletic performance in elite athletes. During a 9-month competitive sports season, a group of eli…
Sponsor: Debre Berhan University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Blood plasma boosts IVF success for men with Low-Quality sperm
Disease control CompletedThe goal of this clinical trial is to learn if platelet rich plasma (PRP) works to improve embryo development rates and embryo quality in IVF cycles, involving male adult patients with severe sperm disorders. The main questions it aims to answer are: * Does PRP improve sperm qu…
Phase 3 • Sponsor: Stella Maris Women and Children Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC